Back to top

genomics: Archive

Zacks Equity Research

Armata Pharma (ARMP) Stock Surges 130% in a Month: Here's Why

Armata Pharma (ARMP) stock skyrockets 130% in a month due to encouraging progress of the company's pathogen-targeting natural and synthetic phage candidates.

DVAXNegative Net Change JNJNegative Net Change CORTNegative Net Change ARMPNegative Net Change

Kevin Cook

Bull of the Day: NVIDIA (NVDA)

Shares have ramped, but analysts still underestimate the King of AI and its new paradigm

NVDAPositive Net Change AMDPositive Net Change MSFTPositive Net Change CDNSNegative Net Change METAPositive Net Change